equol has been researched along with Cancer of Prostate in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 12 (37.50) | 29.6817 |
| 2010's | 18 (56.25) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Bobrowska-Korczak, B; Figat, R; Kiss, AK; Stanisławska, IJ | 1 |
| Allen, NE; Appleby, PN; Boeing, H; Drake, I; Gil, L; Gislefoss, RE; Johansson, A; Key, TJ; Khaw, KT; Kubo, T; Kyrø, C; Landberg, R; Langseth, H; Luben, RN; Mikami, K; Murphy, N; Nilsson, LM; Ozasa, K; Perez-Cornago, A; Ricceri, F; Sawada, N; Sonestedt, E; Stattin, P; Tamakoshi, A; Travis, RC; Trichopoulou, A; Tsilidis, KK; Tsugane, S; Wallström, P | 1 |
| Akaza, H; Fukuta, F; Hida, T; Masumori, N; Minatoya, M; Mori, M; Nagata, Y; Sugiyama, Y; Tsuji, H; Tsukamoto, T; Yamashita, T; Yoneta, A | 1 |
| Akasaka, H; Akaza, H; Fukuta, F; Masumori, N; Miura, T; Mori, M; Moriyama, K; Nagata, Y; Ohnishi, H; Saito, S; Sugiyama, Y; Takayanagi, A; Tsuji, H; Tsukamoto, T | 1 |
| Akaza, H; Miyanaga, N | 1 |
| Guo, J; Kong, Y; Liu, J; Liu, K; Lu, Z; Mi, M; Sun, H; Wang, J; Xia, W; Xu, H; Yang, J; Zhou, R | 1 |
| Akaza, H | 2 |
| Eto, M; Inokuchi, J; Itsumi, M; Kajioka, S; Kashiwagi, E; Naito, S; Shiota, M; Takeuchi, A; Tatsugami, K; Uchiumi, T; Yokomizo, A | 1 |
| Akasaka, H; Akaza, H; Fukuta, F; Masumori, N; Miura, T; Mori, M; Moriyama, K; Nagata, Y; Ohnishi, H; Saitoh, S; Sugiyama, Y; Takayanagi, A; Tsuji, H; Tsukamoto, T | 1 |
| Brooks, JD; Feldman, D; Franke, AA; Gardner, CD; Liu, JP; Oelrich, B | 1 |
| Akaza, H; Chihara, Y; Fujimoto, K; Hirao, Y; Hirayama, A; Miyanaga, N; Tanaka, M; Tanaka, N; Torimoto, K; Yoneda, T | 1 |
| Bennett, FI; Jackson, MD; McFarlane-Anderson, ND; Simon, GA; Walker, SP | 1 |
| deVere White, RW; Fujii, H; Hackman, RM; Soares, SE; Stapp, EC; Tsodikov, A | 1 |
| Blake, C; Bu, L; Hamaker, AN; Lephart, ED; Lund, TD | 1 |
| Krol, W; Szliszka, E | 1 |
| Greiwe, JS; Jackson, RL; Schwen, RJ | 1 |
| Li, G; Ma, D; Wang, P; Zhang, Y; Zheng, W | 1 |
| Akaza, H; Fujioka, T; Hinotsu, S; Hirao, Y; Horie, S; Miyanaga, N; Mori, M; Naito, S; Namiki, M; Takahashi, S; Tsuji, H; Tsukamoto, T | 1 |
| Takahashi, S | 1 |
| Adam, V; Busch, KH; Ekblad, M; Halldén, G; Johnsen, CT; Kang, NR; Lemoine, NR; Müller, H; Sweeney, K | 1 |
| Arisaka, O; Evans, BA; Miyake, N; Morgan, LD; Morton, MS | 1 |
| Hedlund, TE; Johannes, WU; Miller, GJ | 1 |
| Akaza, H; Fujioka, T; Hirao, Y; Kim, WJ; Miyanaga, N; Mori, M; Naito, S; Pantuck, AJ; Song, JM; Takashima, N; Tsukamoto, T | 1 |
| Atkinson, C; Frankenfeld, CL; Lampe, JW | 1 |
| Chandramouli, GV; Hursting, SD; Kim, YS; Lavigne, JA; Perkins, SN; Takahashi, Y; Wang, TT | 1 |
| Duffin, JG; Jokela, T; Magee, PJ; Pool-Zobel, BL; Raschke, M; Rowland, IR; Steiner, C; Wahala, K | 1 |
| Alexander, FE; Bolton-Smith, C; Heald, CL; Morton, MS; Ritchie, MR | 1 |
| Vastag, B | 1 |
| Anai, S; Chang, M; Hou, W; Pendleton, JM; Rosser, CJ; Shiverick, KT; Tan, WW | 1 |
| Adlercreutz, H; Markkanen, H; Watanabe, S | 1 |
| Collins, AR; Duthie, SJ; Mitchell, JH | 1 |
6 review(s) available for equol and Cancer of Prostate
| Article | Year |
|---|---|
Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls.
Topics: Aged; Case-Control Studies; Equol; Europe; Genistein; Humans; Isoflavones; Japan; Lignans; Male; Middle Aged; Phytoestrogens; Prospective Studies; Prostatic Neoplasms; Risk Factors | 2018 |
Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk.
Topics: Bacteria; Equol; Feces; Food; Gastrointestinal Tract; Humans; Isoflavones; Male; Metabolome; Prostatic Neoplasms | 2013 |
Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.
Topics: Biomarkers; Biotransformation; C-Reactive Protein; Cardiovascular Diseases; Equol; Estrogen Receptor beta; Female; Humans; Intestines; Isoflavones; Lipoproteins, LDL; Male; Osteoporosis; Phytoestrogens; Prostatic Neoplasms; Risk Factors | 2011 |
Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome".
Topics: Actinobacteria; Bacteria; Controlled Clinical Trials as Topic; Diet; Equol; Genome, Human; Glycine max; Humans; Intestines; Isoflavones; Male; Metagenome; Prostatic Neoplasms | 2012 |
Editorial comment to involvement of estrogen receptors in prostatic diseases.
Topics: Diet; Equol; Estrogen Receptor Modulators; Humans; Isoflavones; Male; Prostatic Neoplasms; Receptors, Estrogen | 2012 |
Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Topics: Bacteria; Breast Neoplasms; Equol; Estrogens, Non-Steroidal; Female; Glycine max; Humans; Intestinal Mucosa; Intestines; Isoflavones; Male; Prostatic Neoplasms; Surveys and Questionnaires | 2005 |
4 trial(s) available for equol and Cancer of Prostate
| Article | Year |
|---|---|
Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
Topics: Adenocarcinoma; Dietary Supplements; Double-Blind Method; Equol; Genistein; Glycine max; Humans; Isoflavones; Male; Mass Spectrometry; Prostatic Neoplasms; Statistics, Nonparametric | 2009 |
Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Dietary Supplements; Double-Blind Method; Equol; Genistein; Glycine max; Humans; Isoflavones; Male; Middle Aged; Phytotherapy; Plant Extracts; Polysaccharides; Prostate-Specific Antigen; Prostatic Neoplasms; Severity of Illness Index; Time Factors | 2010 |
Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.
Topics: Administration, Oral; Aged; Double-Blind Method; Equol; Humans; Isoflavones; Japan; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms | 2012 |
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
Topics: Adenocarcinoma; Aged; Dietary Supplements; Equol; Genistein; Humans; Isoflavones; Male; Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Receptors, Androgen | 2008 |
22 other study(ies) available for equol and Cancer of Prostate
| Article | Year |
|---|---|
Essential Elements and Isoflavonoids in the Prevention of Prostate Cancer.
Topics: Equol; Flavones; Genistein; Humans; Male; Prostate; Prostatic Neoplasms | 2022 |
Counts of Slackia sp. strain NATTS in intestinal flora are correlated to serum concentrations of equol both in prostate cancer cases and controls in Japanese men.
Topics: Actinobacteria; Adult; Aged; Case-Control Studies; Equol; Feces; Follow-Up Studies; Humans; Intestinal Mucosa; Intestines; Isoflavones; Male; Middle Aged; Prognosis; Prostatic Neoplasms | 2014 |
[Prostate cancer prevention].
Topics: Equol; Feeding Behavior; Humans; Isoflavones; Male; Obesity; Prostatic Neoplasms; Risk Factors | 2015 |
S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Products; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Equol; Forkhead Box Protein O3; G2 Phase Cell Cycle Checkpoints; Humans; Isoflavones; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2016 |
[Epidemiology and prevention].
Topics: Aging; Diet; Equol; Humans; Isoflavones; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors | 2016 |
Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydrotestosterone; Equol; Humans; Male; Phytoestrogens; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; S-Phase Kinase-Associated Proteins | 2016 |
Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.
Topics: Actinobacteria; Aged; Case-Control Studies; Diet; Equol; Feces; Genistein; Humans; Isoflavones; Japan; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Surveys and Questionnaires | 2016 |
Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.
Topics: Adult; Cholesterol; Dietary Supplements; Dihydrotestosterone; Equol; Genistein; Humans; Isoflavones; Male; Middle Aged; Prostatic Neoplasms; Sex Hormone-Binding Globulin | 2009 |
Urinary phytoestrogens and risk of prostate cancer in Jamaican men.
Topics: Aged; Carcinoma; Case-Control Studies; Equol; Genistein; Humans; Isoflavones; Jamaica; Lignans; Male; Middle Aged; Phytoestrogens; Prostatic Neoplasms; Risk | 2010 |
Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivo evidence.
Topics: Animals; Cell Line, Tumor; Dihydrotestosterone; Equol; Humans; Isoflavones; Male; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Rats | 2011 |
Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cytotoxins; Equol; Genistein; Glycine max; Humans; Isoflavones; Male; Membrane Potential, Mitochondrial; Plant Extracts; Prostatic Neoplasms; Receptors, Death Domain; TNF-Related Apoptosis-Inducing Ligand | 2011 |
[Anti-invasion effects of R- and S-enantiomers of equol on prostate cancer PC3, DU145 cells].
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Equol; Humans; Male; Neoplasm Invasiveness; Phytoestrogens; Prostatic Neoplasms; Stereoisomerism | 2011 |
Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models.
Topics: Adenoviridae; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Dietary Supplements; Equol; Humans; Male; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Oncolytic Viruses; Phytoestrogens; Prostatic Neoplasms; Resveratrol; Stilbenes; Transplantation, Heterologous | 2012 |
Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.
Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chromans; Diet; Equol; Estrogens, Non-Steroidal; Female; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Japan; Lignans; Male; Middle Aged; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; United Kingdom | 2002 |
Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Topics: Apoptosis; Cell Cycle; Cell Division; Chromans; Diet; Enzyme Inhibitors; Equol; Estrogens, Non-Steroidal; Flow Cytometry; Genistein; Humans; Isoflavones; Male; Plant Proteins; Polysaccharides; Prostate; Prostatic Neoplasms; Soy Foods; Tumor Cells, Cultured | 2003 |
Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Diet; Equol; Genistein; Humans; Incidence; Isoflavones; Japan; Korea; Male; Middle Aged; Prostatic Neoplasms; United States | 2004 |
Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.
Topics: Androgens; Cell Cycle; Cell Line, Tumor; Equol; Gene Expression; Gene Expression Profiling; Genistein; Glycine max; Humans; Insulin-Like Growth Factor I; Isoflavones; Male; Neoplasms, Hormone-Dependent; Oligonucleotide Array Sequence Analysis; Phytoestrogens; Prostatic Neoplasms; Receptor, IGF Type 1 | 2006 |
Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line, Tumor; Comet Assay; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Equol; Female; Humans; Isoflavones; Male; Phytoestrogens; Prostatic Neoplasms; Receptors, Estrogen; Stereoisomerism | 2006 |
Phyto-oestrogens and risk of prostate cancer in Scottish men.
Topics: 4-Butyrolactone; Aged; Case-Control Studies; Diet; Diet Surveys; Energy Intake; Equol; Genistein; Humans; Isoflavones; Lignans; Male; Middle Aged; Phytoestrogens; Prostatic Neoplasms; Risk Assessment; Scotland | 2007 |
Soy and prostate cancer study results mixed.
Topics: Anticarcinogenic Agents; Equol; Feeding Behavior; Genistein; Humans; Intestines; Isoflavones; Japan; Male; Phytoestrogens; Prostatic Neoplasms; Soy Foods | 2007 |
Plasma concentrations of phyto-oestrogens in Japanese men.
Topics: Chromans; Diet; Equol; Estrogens, Non-Steroidal; Finland; Genistein; Humans; Isoflavones; Japan; Male; Middle Aged; Prostatic Neoplasms; Risk Factors | 1993 |
Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Cell Transformation, Neoplastic; Chromans; Coumestrol; DNA Damage; Equol; Estrogens, Non-Steroidal; Genistein; Humans; Isoflavones; Male; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Tumor Cells, Cultured | 2000 |